Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate /

Similar Items

• Drug safety: FDA's future inspection plans need to address issues presented by COVID-19 backlog : testimony before the Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Committee on Appropriations, House of Representatives /
  by: Denigan-Macauley, Mary
  Published: (2021)
• Preclinical and clinical testing by the pharmaceutical industry, 1978 : hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, United States Senate, Ninety-fifth Congress, second session ..
  Published: (1978)
• The effectiveness of substance abuse education and treatment programs in prevention of crime : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, second session, July 29, 2002.
  Published: (2003)
• The effectiveness of substance abuse education and treatment programs in prevention of crime : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, second session, July 29, 2002
  Published: (2003)
• Assessing the safety of our nation's drug supply : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 9, 2007.
  Published: (2008)